0 Comments
0 Shares
929 Views
0 Reviews
Sponsored
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Global Demand for Inactivated Vaccines: Trends and InsightsWhat is the projected growth rate (CAGR) of the Inactivated Vaccines Market from 2024 to 2031, and what is the market value expected to change by 2031? The Global Inactivated Vaccines Market reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032. What is the Inactivated Vaccines Market? This market...0 Comments 0 Shares 949 Views 0 Reviews
-
Inactivated Vaccines Market Share and Future Scope“Global Inactivated Vaccines Market reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032”, according to DataM intelligence report. Inactivated vaccines are created by *** the disease-causing microorganisms using heat, chemicals, or radiation. Unlike live vaccines, these do not...0 Comments 0 Shares 874 Views 0 Reviews
-
mRNA Vaccines Redefined: CI Insights into Innovation, Platforms, and Market ExpansionMessenger RNA (mRNA) vaccines have emerged as a transformative force in the global fight against infectious diseases, with their rapid development, adaptability, and precision mechanism driving a new era of preventive medicine. Once considered experimental, mRNA technology now stands at the forefront of vaccine innovation, with expanding applications in infectious disease, oncology, and...0 Comments 0 Shares 1K Views 0 Reviews
-
USDA’s Poultry Vaccine Plan Accelerates USD 12B+ Veterinary Vaccines IndustryThe global veterinary vaccines market is entering a phase of sustained growth and innovation, with mounting demand from both companion animal and livestock sectors. According to recent data, market valuation reached USD 12.05 billion in 2024 and is forecast to climb to USD 12.51 billion in 2025 and USD ***56 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.8%. Meanwhile,...0 Comments 0 Shares 1K Views 0 Reviews
-
Viral Vector Vaccines Market to Surpass USD 2.6 Billion by 2032: Key Players, Segments, and Growth ForecastThe global Viral Vector Vaccines Market was valued at USD 850.43 million in 2024 and is expected to grow at a CAGR of 15.93% between 2025 and 2032. Fueled by rising infectious disease prevalence and innovations in genetic engineering, viral vector vaccines have become critical tools in modern immunology. According to a recent report by AnalystView Market Insights (Report Code: AV4115), this...0 Comments 0 Shares 474 Views 0 Reviews
-
Global Immunization Growth Powers Live Attenuated Vaccine DemandThe Live Attenuated Vaccines Market is experiencing rapid expansion, projected to grow from USD 25.3 billion in 2023 to USD 70.4 billion by 2032. The market is driven by increased demand for robust, long-lasting immunizations, innovations in oral and intranasal delivery systems, and rising infectious disease threats worldwide. Growth is especially strong in the United States, Japan, and across...0 Comments 0 Shares 2K Views 0 Reviews
-
Screening & Awareness Initiatives Bolster Hepatitis B *** UptakeThe global Hepatitis B Treatment Market is positioned for consistent growth, with market valuation expected to increase from USD 4.5 billion in 2023 to USD 7.3 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2024–2032). The rise in chronic hepatitis B cases globally, combined with growing awareness, treatment accessibility, and a strong pipeline of advanced...0 Comments 0 Shares 2K Views 0 Reviews
Sponsored
Arabic
עברית
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek